123 related articles for article (PubMed ID: 8903968)
1. Functional characterization of the human neurokinin receptors NK1, NK2, and NK3 based on a cellular assay system.
Stratowa C; Machat H; Burger E; Himmler A; Schafer R; Spevak W; Weyer U; Wiche-Castanon M; Czernilofsky AP
J Recept Signal Transduct Res; 1995; 15(1-4):617-30. PubMed ID: 8903968
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a cellular assay system for G protein-linked receptors: coupling of human NK2 and 5-HT2 receptors to phospholipase C activates a luciferase reporter gene.
Weyer U; Schäfer R; Himmler A; Mayer SK; Bürger E; Czernilofsky AP; Stratowa C
Recept Channels; 1993; 1(3):193-200. PubMed ID: 7522900
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
4. Effect of neurokinins on canine prostate cell physiology.
Walden PD; Marinese D; Srinivasan D; Tzoumaka E; Syyong HT; Ford AP; Bhattacharya A
Prostate; 2005 Jun; 63(4):358-68. PubMed ID: 15611996
[TBL] [Abstract][Full Text] [Related]
5. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
6. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line.
Subramanian N; Ruesch C; Bertrand C
Biochem Biophys Res Commun; 1994 May; 200(3):1512-20. PubMed ID: 8185607
[TBL] [Abstract][Full Text] [Related]
8. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
11. Further identification of neurokinin receptor types and mechanisms of calcium signaling evoked by neurokinins in the murine neuroblastoma C1300 cell line.
Fukuhara S; Mukai H; Kako K; Nakayama K; Munekata E
J Neurochem; 1996 Sep; 67(3):1282-92. PubMed ID: 8752137
[TBL] [Abstract][Full Text] [Related]
12. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.
Jeurissen F; Kavelaars A; Korstjens M; Broeke D; Franklin RA; Gelfand EW; Heijnen CJ
J Immunol; 1994 Mar; 152(6):2987-94. PubMed ID: 7511635
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
14. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
15. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Lippi A; Guelfi M; Quartara L; Maggi CA
Biochem Biophys Res Commun; 1998 Jul; 248(1):78-82. PubMed ID: 9675089
[TBL] [Abstract][Full Text] [Related]
17. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
18. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
Lördal M; Bränström R; Hellström PM
Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
[TBL] [Abstract][Full Text] [Related]
19. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
20. Characterization of [3H]substance P binding sites in human skin.
Bianchi B; Matucci R; Danesi A; Rossi R; Ipponi P; Giannotti B; Johansson O; Cappugi P
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):6-10. PubMed ID: 10188142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
